CANCER SUBTYPE PLATFORM

Brand Owner (click to sort) Address Description
CSP GENECENTRIC DIAGNOSTICS, INC. 4401 Research Commons, Suite 105 79 TW Alexander Drive Research Triangle Park NC 27709 CANCER SUBTYPE PLATFORM;Providing medical, scientific and pharmaceutical research services; Providing medical research and scientific research information in the field of oncology; Providing medical and scientific research services in the field of cancer diagnosis, prognosis, therapy, prevention, treatment and patient management; Providing research and development service in the pharmaceutical and biotechnology fields; Research and development in the field of gene expression, namely, cancer biology; Providing medical and scientific research services and information in the field of clinical trials; Research and development services for others, namely, research and development of assays for oncological testing, treatment and diagnostic purposes; Scientific research in the field of genome sequence analysis and reporting;
CSP GENECENTRIC THERAPEUTICS, INC. 4401 Research Commons, Suite 105 79 TW Alexander Drive Research Triangle Park NC 27709 CANCER SUBTYPE PLATFORM;Medical services; Medical testing for diagnostic, treatment or screening purposes; Medical services, namely, cell and gene therapy; Providing molecular genetics and genomics testing and reporting services in the field of biomarkers for the diagnosis, prognosis, treatment or management of cancer;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. An HIV-1 type (or subtype) O retrovirus protein, or a natural or synthetic polypeptide or peptide including at least a part of said protein, which is capable of being recognised by antibodies isolated from a serum resulting from infection by an HIV-1 type O VAU strain or an HIV-1 type (or subtype) O DUR strain.